Effect of Sodium Alendronate on the Final Implant Stability.

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05162885
Collaborator
(none)
24
1
2
17
1.4

Study Details

Study Description

Brief Summary

evaluation of the final implant stability after its placement in sockets preserved with two different socket preservation materials

Condition or Disease Intervention/Treatment Phase
  • Procedure: Socket Preservation technique
Early Phase 1

Detailed Description

compare the stability of implant placement using Osstell ISQ "resonance frequency analyzer", and marginal bone resorption and bone density around implant by X-ray analysis in different socket preservation techniques comparing sodium alendronate with the sticky bone graft technique

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Sodium Alendronate Versus Sticky Bone as Socket Preservation Materials on the Final Implant Stability. A Randomized Clinical Trial
Actual Study Start Date :
May 1, 2021
Actual Primary Completion Date :
May 23, 2021
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: implant placement in defective Sockets preserved with alendronic acid sponge

anesthesia according the site of implant placement were administered using mepivacaine HCl (2%) with levonordefrin 1:20 000 (Scandonest 2%; Septodont, Saint- Maur-des-Fossés, France). Injection to control pain and bleeding for hemostasis. Crestal incision with a full thickness mucoperiosteal flap was reflected .A pilot drill will be used to start the osteotomy preparation, then different drilling sizes will be used to attain the final drill size and the planed implant height and width according to Cone Beam CT. Implants were screwed directly into the osteotomy site, primarily the screwing was done mechanically by Fixture Mount Connection attached to the implant carrier. The created gap sutured passively to allow tension-free interrupted closure using 3-0 coated undyed braided polyglactin 910 suture material.

Procedure: Socket Preservation technique
Implant placement after Socket preservation Technique with sodium alderonate versus sticky bone in salama&salama Class 3 labial wall defect
Other Names:
  • Implant in socket preserved with sodium alenderonate drug
  • Active Comparator: Implant placement in Defective sockets preserved with sticky bone

    anesthesia according the site of implant placement were administered using mepivacaine HCl (2%) with levonordefrin 1:20 000 (Scandonest 2%; Septodont, Saint- Maur-des-Fossés, France). Injection to control pain and bleeding for hemostasis. Crestal incision with a full thickness mucoperiosteal flap was reflected .A pilot drill will be used to start the osteotomy preparation, then different drilling sizes will be used to attain the final drill size and the planed implant height and width according to Cone Beam CT. Implants were screwed directly into the osteotomy site, primarily the screwing was done mechanically by Fixture Mount Connection attached to the implant carrier. The created gap sutured passively to allow tension-free interrupted closure using 3-0 coated undyed braided polyglactin 910 suture material.

    Procedure: Socket Preservation technique
    Implant placement after Socket preservation Technique with sodium alderonate versus sticky bone in salama&salama Class 3 labial wall defect
    Other Names:
  • Implant in socket preserved with sodium alenderonate drug
  • Outcome Measures

    Primary Outcome Measures

    1. Implant stability [3-4 months after Dental implant placement]

      Calculate the final implant stability of two groups using Osstell "resonance frequency analyzer"

    Secondary Outcome Measures

    1. marginal bone [3-4 months after Dental implant placement]

      Evaluation of marginal bone resorption around implant in two groups using superimposition x-ray (CBCT) software analysis

    Other Outcome Measures

    1. Bone Density [3-4 months after Dental implant placement]

      Evaluation of bone density around the placed implants using x-ray (CBCT) software analysis

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients with seeking implant drive prosthesis after socket has been preserved by either technique.

    • Patients with seeking implant drive prosthesis with Salama Class 3 defective sockets.

    • Both genders males and females will be included.

    Exclusion Criteria:
    • General contraindications to implant surgery.

    • Patient seeking immediate implant placement.

    • Subjected to irradiation in the head and neck area less than 1 year before implantation.

    • Untreated periodontitis.

    • Poor oral hygiene and motivation.

    • Uncontrolled diabetes.

    • Pregnant or nursing.

    • Substance abuse.

    • Psychiatric problems or unrealistic expectations.

    • Severe bruxism or clenching.

    • Immunosuppressed or immunocompromised.

    • Treated or under treatment with intravenous amino-bisphosphonates.

    • Active infection or severe inflammation in the area intended for implant placement.

    • Unable to open mouth sufficiently to accommodate the surgical tooling.

    • Patients participating in other studies, if the present protocol could not be properly

    • followed. Referred only for implant placement or unable to attend a 5-year follow-up

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hossam Abdallah Mohammed Ghazally Cairo Manial Egypt 11553

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hossam Abdallah Mohammed Ghazzaly, H.Ghazzaly, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05162885
    Other Study ID Numbers:
    • omfs335
    First Posted:
    Dec 17, 2021
    Last Update Posted:
    Dec 17, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Hossam Abdallah Mohammed Ghazzaly, H.Ghazzaly, Cairo University

    Study Results

    No Results Posted as of Dec 17, 2021